$1.08
-0.01-0.92%
Last update: Nov 10, 9:05 AM
Gain Therapeutics Inc
GANXNASDAQ
The average analyst price target for Gain Therapeutics is $7.56, 575.0% above the current price. Of 7 analysts, 7 rate it Buy. Targets range from $5 to $12. The latest change came on Oct 16, 2025, when BTIG lowered its price target on Gain Therapeutics from $9 to $5 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
